Panel Discussions on Engineering in Surgery and Intervention

Careers from Entrepreneur to Enterprise Part II


February 28, 2023, 6 - 6:30pm CST
Online Webinar

event-esi (1)
esi-event-2 (1)

About the event

Would you like to hear from industry leaders and entrepreneurs who are actively engaged in an engineering career associated with surgery and intervention? Here’s your chance. This two-part webinar series will feature a focused 30-minute discussion from folks that span the industrial spectrum from startup to major enterprise to include commercial development partner.  
 
Each of these panel members has a unique perspective on the field of engineering and its impact on surgery and intervention, and what careers in this dynamic domain are all about.
 
In Part II, we explore the fast-paced and kinetic world of the entrepreneur with Piotr Slawinksi, PhD, Technical Lead, Robotics and Controls at the startup Noah Medical, and Jim Stefansic, PhD, Director of Corporate Development at Cumberland Emerging Technologies.  You will hear directly as to what it is like to be working in the highly competitive startup market as well as the from the corporate partners working with these entrepreneurs to help them realize their vision.

Piotr Slawinksi

piotr_headshot-1

Piotr Slawinski, Technical Lead - Robotics and Controls at Noah Medical, received his PhD from Vanderbilt University in2019 as an NSF Graduate Research Fellow. His research interests have included robotic endoscopy, magnetic actuationof medical robots, and capsule endoscopy. After graduating, Piotr joined Noah Medical.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Jim Stefansic

Jim-Headshot-PHC-2018

Jim Stefansic is the Director of Corporate Development at Cumberland Emerging Technologies (CET). His responsibilities include sourcing, evaluating, and negotiating for new biopharmaceutical product and technology opportunities especially with academic institutions, in addition to project fundraising and product commercialization. Dr. Stefansic was previously COO of Pathfinder Therapeutics, Inc., a company he co founded, where he led FDA regulatory submissions and business development activities. While there, he raised more than $17 million in venture capital and Small Business Innovation Research (SBIR) funding. He also previously served as the Director of Commercialization at Launch Tennessee, where he was instrumental in leading the acquisition of funding to develop and support the statewide SBIR program. He earned an undergraduate degree in biomedical engineering from Johns Hopkins University, a doctorate from Vanderbilt, and his MBA from Belmont University's Jack C. Massey Graduate School of Business, where he currently serves as an Adjunct Professor of Business and was named the Distinguished Alumnus of the Year in 2011. Dr. Stefansic started his career as a Research Assistant Professor at Vanderbilt University Medical Center and has patented several technologies. He also serves as a Director at Raiven Healthcare,
an AI analytics company he co-founded and recently sold to a private equity group.

Join a community of mission-driven surgical engineers at Vanderbilt University School of Engineering.

Request More Information